Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

BiOasis Technologies Inc V.BTI

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s): BIOAF

biOasis Technologies, Inc. is a development stage biopharmaceutical company engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders.
Price: $1.07 | Change: $0.00 | % Change: 0.00%
Volume: 0 | Day High/Low: N/A/N/A | 52 Week High/Low: 1.45/0.67

View modes: 
5 stars

RE:RE:RE:RE:RE:"...continuing our BT2111 program at a number of locations."

the mice survived until they were euthenized.   mice are grown with the intended condition to test against. they did 3 groups, control, herceptin alone and bt2111. all mice had tumors. all mice in...read more
0 stars

RE:RE:RE:RE:"...continuing our BT2111 program at a number of locations."

"Maybe there just isn't anything to say !!" The survival data exists, period, for BT2111. How long did the mice survive?  rate and reply
1 star

Roche - Kadcyla

Breast cancer drug turned down for NHS use due to high cost Sarah Boseley, health editor The Guardian, Wednesday 23 April 2014     A Herceptin-style drug that can offer some women with advanced...read more
3.5 stars

RE:RE:RE:"...continuing our BT2111 program at a number of locations."

Maybe there just isn't anything to say !!  rate and reply
3 stars

RE:RE:"...continuing our BT2111 program at a number of locations."

there are many things to consider regarding news, such as the filing of Intellectual Property Patents - we've had a ver busy year with regards to IP and as soon as our Lawyers tell me we legally all...read more
1 star

RE:"...continuing our BT2111 program at a number of locations."

We also don't know the efficacy/survival results for BT2111. According to a news release efficacy results were due mid-to-late summer. That was seven months ago. According to the following IP issues...read more
5 stars

"...continuing our BT2111 program at a number of locations."

Nearly six months ago (Nov.12, 2013) RH said this "We are continuing our BT2111 program at a number of locations."  No news whatsoever!  It's no wonder shareholders continue to be frustrated. FYI...read more
1 star

RE:RE:RE:sooooooooo

who would ever want to duplicate a loser like you?.....one minute youre telling people with the same opinion like mine to stfu...the next u turn 360 degrees saying how mad u are at the companys...read more
0 stars

RE:RE:sooooooooo

well, i've reserved judgement for some time but it has to be said..... someone here is USELESS!   what on God's green earth are we waiting for?   #toindwbmahbnDRJ! and..... the often imitated never...read more
2.5 stars

RE:RE:sooooooooo

bti has allready and if not should have been getting calls from angry shareholders....i have made my point to them aswell....question to the board?...hows the dead money treating u guys?,,,,while...read more
5 stars

RE:sooooooooo

I have in fact got in touch with Liolios after left messages & repeated call back. In general,  I don't have the confidence that these guys are as up-to-date on the story as their counter part in...read more
3 stars

sooooooooo

here we are, an entirely new week after a long weekend........sigh...................   anyone here from liolios yet?   #toindwbmahbnDRJ!  rate and reply
3 stars

Strong bargaining position

~7 months into publically claiming to be ready to license only one evaluation agreement signed. Lots of cash left! No pressure!  rate and reply
3.5 stars

RE:Sanfilippo syndrome (MPS-III)

Nice posts KayakerBC. Can anyone comment of how long it takes to make a Transcend/therapeutic conjugate for the first time?  Is it something that can "easily" be created?  The reason I ask is because...read more
2.5 stars

RE:RE:AstraZeneca

Bloomberg video clip on Pfizer/AstraZeneca Pfizer ‘Informal’ Talks With AstraZeneca Broke Off April 21 (try not to get too distracted by Stephanie Ruhle) LINK  rate and reply
3.5 stars

RE:AstraZeneca

I know these takeover rumours are a regular event.  With that in mind, here are comments on Pfizer/AstraZeneca from John LaMattina at Forbes.... (The link is a mess in FF and IE but works OK in...read more
3 stars

RE:RE:Sanfilippo syndrome (MPS-III)

BT2111 (or many others), or Sanfilippo syndrome (MPS-III).  It is one of the lysosomal storage diseases that BTI could/should be able to treat. From the BTI patent "Use of p97 as an enzyme delivery...read more
0 stars

RE:Sanfilippo syndrome (MPS-III)

Great stuff Kayaker.  So what we need is a victim who could plausibly be helped by BT2111 whose family is willing to go on camera with their plight -- and then a researcher to whom crowd-funded...read more
5 stars

Sanfilippo syndrome (MPS-III)

#SavingEliza: Parents use viral video to try to save their 4-year-old's life Linda Carroll TODAY contributor April 21, 2014 Cara and Glenn O’Neill were stunned when doctors diagnosed a deadly, rare...read more
0 stars

RE:Nice start

Hi lioliololios.....what are youbguys doing today????...still on vacation are we or do you even plan on doing anything on shareholders behalfs???  rate and reply